Dalila Bouyoucef-Cherchalli - JoVE Visualize

Showing results (1-10 of 4) with videos related to

Pageof 1

Sort By:

Molecular and Cellular Biology|May 13, 2009

The ability of GAP1IP4BP to function as a Rap1 GTPase-activating protein (GAP) requires its Ras GAP-related domain and an arginine finger rather than an asparagine thumbSabine Kupzig, Dalila Bouyoucef-Cherchalli, Sam Yarwood, et al.

Plos One|March 3, 2012

IP3 3-kinase opposes NGF driven neurite outgrowthRichard Eva, Dalila Bouyoucef-Cherchalli, Kalpana Patel, et al.

British Journal of Clinical Pharmacology|September 24, 2021

Healthy volunteers in first-in-human oncology drug development for small moleculesBegoña de Las Heras, Dalila Bouyoucef-Cherchalli, Lesley Reeve, et al.

British Journal of Cancer|August 5, 2026

A Phase 1/2 study of ontorpacept (TTI-621) in combination with doxorubicin in patients with unresectable or metastatic high-grade leiomyosarcomaSujana Movva, Victoria Allgood, Rashmi Chugh, et al.

Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:

Pageof 1

Molecular and Cellular Biology|May 13, 2009

The ability of GAP1IP4BP to function as a Rap1 GTPase-activating protein (GAP) requires its Ras GAP-related domain and an arginine finger rather than an asparagine thumbSabine Kupzig, Dalila Bouyoucef-Cherchalli, Sam Yarwood, et al.

Plos One|March 3, 2012

IP3 3-kinase opposes NGF driven neurite outgrowthRichard Eva, Dalila Bouyoucef-Cherchalli, Kalpana Patel, et al.

British Journal of Clinical Pharmacology|September 24, 2021

Healthy volunteers in first-in-human oncology drug development for small moleculesBegoña de Las Heras, Dalila Bouyoucef-Cherchalli, Lesley Reeve, et al.

British Journal of Cancer|August 5, 2026

A Phase 1/2 study of ontorpacept (TTI-621) in combination with doxorubicin in patients with unresectable or metastatic high-grade leiomyosarcomaSujana Movva, Victoria Allgood, Rashmi Chugh, et al.

Pageof 1